To further study this possibility, we decided to analyze the expression levels of the JAG1, which encodes for Jagged1, one of the most important canonical NOTCH receptor ligands in breast cancer [27], as well as the expression levels of the four NOTCH receptor genes in our DLK2-overexpressing cells. This evidence concerns the gene DLK2 and breast carcinoma.